Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: Recent advances in monitoring

Pediatric Transplantation

Volumn 13, Issue 5, 2009, Pages 606-610

  Elidemir, Okan ^a,b   Kancherla, Binal S ^b   Schecter, Marc G ^b   McKenzie, E Dean ^a   Morales, David L ^a   Heinle, Jeffrey S ^a   Mallory, George B ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b Department of Pediatrics   (United States)

Author keywords

EBV; Immunosuppression; Lung transplantation; Pediatric; Post transplant lymphoproliferative disease

Indexed keywords

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; RETRANSPLANTATION; RETROSPECTIVE STUDY; VIRUS LOAD;

BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CASE-CONTROL STUDIES; CHILD; CYCLOSPORINE; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MONITORING, PHYSIOLOGIC; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 67651183952     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01085.x     Document Type: Article

References (15)

1. Boyle GJ, Michaels MG, Webber SA, et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr 1997 : 131 : 309 313.
2. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004 : 4 : 222 230.
3. Rogers BB, Sommerauer J, Quan A, et al. Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: Three-year experience. Pediatr Dev Pathol 1998 : 1 : 480 486.
4. Gautam A, Morrissey EP, Brem As, et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant 2006 : 10 : 613 616.
5. Reams BD, McAdams HP, Howell DN, et al. Posttransplant lymphoproliferative disorder: Incidence, presentation, and response to treatment in lung transplant recipients. Chest 2003 : 124 : 1242 1249.
6. Raj R, Frost AE. Lung retransplantation after PTLD: A single center experience and review of literature of PTLD in lung transplant recipients. J Heart Lung Transplant 2005 : 24 : 671 679.
7. Benden C, Aurora P, Burch M, et al. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction. J Heart Lung Transplant 2005 : 24 : 2103 2108.
8. Cohen AH, Sweet SC, Mendeloff E, et al. High incidence of PTLD in pediatric patients with cystic fibrosis. Am J Respir Crit Care Med 2000 : 161 : 1252 1255.
9. Chmiel JF, Davis PB. State of the art: Why do the lungs of patients with cystic fibrosis become infected and why cannot they clear the infection? Respir Res 2003 : 4 : 8.
10. Hartl D, Griese M, Kappler M, et al. Pulmonary TH-2 response in Pseudomonas aeruginosa infected patients with cystic fibrosis. J Allergy Clin Immunol 2006 : 117 : 204 211.
11. Hubeau C, Le Naour R, Abely M, et al. Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin Exp Immunol 2004 : 135 : 528 534.
12. Moss RB. Lymphocytes in cystic fibrosis lung disease: A tale of two immunities. Clin Exp Immunol 2004 : 135 : 358 360.
13. Tsai DE, Nearey M, Hardy CL, et al. Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients. Am J Transplant 2002 : 2 : 946 954.
14. Schubert S, Renner C, Hammer M, et al. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric hear transplant patients. J Heart Lung Transplant 2008 : 27 : 100 105.
15. Ganschow R, Schulz T, Meyer T, Broering DC, Burdelski M. Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients. J Pediatr Gastroenterol Nutr 2004 : 38 : 198 203.